MarketPeel
Pricing
…
MM

Mark Christopher Murray

AVTR
EVP, BIOMATERIALS & AT · AVANTOR, INC. · CIK 0001800013
FILING MIX · LIFETIME67%/33%
BUYS
18
SELLS
9
TOTAL VALUE
$1.02M
COMPANIES
2
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
49,112
AVG SELL PX
$69.58
TRADE KIND
SHOWING 27 / 27
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
6 backtested trades · 8 horizons · 3 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Mark Christopher Murray, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d6+100.00%+3.22%+0.03%+3.18%+3.91%—
14d6+83.33%+4.12%+0.90%+3.22%+4.37%—
30d6+66.67%-0.81%+0.46%-1.26%+2.31%—
60d6+50.00%+1.44%+3.89%-2.46%-2.65%—
90d6+16.67%-1.83%+6.50%-8.33%-11.83%—
180d6+50.00%-2.00%+10.30%-12.30%-18.21%—
1y6+66.67%+2.24%+22.99%-20.75%-22.04%—
2y6(3 pending)+0.00%-56.44%+43.99%-100.44%-101.56%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
AVTR · 18,680 shares · as of Jan 13, 2022
030,02760,05490,080120,10720212022SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 18 buys / 9 sellsCOVERAGE · 27 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CE
CELANESE CORP
PURCHASE
SVP - Acetyls
2,153$45.52$98.0K30,432Aug 11, 2026Aug 12, 2026 ↗View →
CE
CELANESE CORP
PURCHASEGRANT
Stock grant
14,561——14,561Feb 27, 2026Mar 3, 2026 ↗View →
CE
CELANESE CORP
PURCHASEGRANT
Stock grant
10,431——28,279Feb 27, 2026Mar 3, 2026 ↗View →
CE
CELANESE CORP
SALE
SVP - Acetyls
357$59.12$21.1K17,848Feb 15, 2026Feb 18, 2026 ↗View →
CE
CELANESE CORP
PURCHASEGRANT
Stock grant
1,205——18,205Feb 15, 2026Feb 18, 2026 ↗View →
CE
CELANESE CORP
PURCHASE
SVP - Acetyls
2,017$41.83$84.4K17,000Aug 14, 2025Aug 18, 2025 ↗View →
CE
CELANESE CORP
SALE
SVP - Acetyls
485$60.85$29.5K14,983Jul 13, 2025Jul 15, 2025 ↗View →
CE
CELANESE CORP
PURCHASE
SVP - Acetyls
1,479$52.18$77.2K15,468May 23, 2025May 28, 2025 ↗View →
CE
CELANESE CORP
PURCHASE
SVP - Acetyls
2,353$54.45$128.1K13,989Mar 7, 2025Mar 10, 2025 ↗View →
CE
CELANESE CORP
PURCHASEGRANT
Stock grant
19,027——19,027Feb 26, 2025Feb 28, 2025 ↗View →
CE
CELANESE CORP
SALE
SVP - Acetyls
364$69.13$25.2K11,636Feb 15, 2025Feb 19, 2025 ↗View →
CE
CELANESE CORP
PURCHASEGRANT
Stock grant
871——12,000Feb 15, 2025Feb 19, 2025 ↗View →
CE
CELANESE CORP
SALE
SVP - Acetyls
471$140.58$66.2K11,129Jul 13, 2024Jul 16, 2024 ↗View →
CE
CELANESE CORP
PURCHASE
SVP - Acetyls
597$156.43$93.4K11,600Mar 8, 2024Mar 11, 2024 ↗View →
CE
CELANESE CORP
PURCHASEGRANT
Stock grant
8,804——8,804Feb 28, 2024Mar 1, 2024 ↗View →
CE
CELANESE CORP
SALE
SVP - Acetyls
124$150.82$18.7K11,003Feb 15, 2024Feb 20, 2024 ↗View →
CE
CELANESE CORP
SALE
SVP - Acetyls
470$122.13$57.4K11,127Jul 13, 2023Jul 17, 2023 ↗View →
CE
CELANESE CORP
PURCHASE
SVP - Acetyls
1,008$101.69$102.5K11,597May 12, 2023May 15, 2023 ↗View →
CE
CELANESE CORP
PURCHASEGRANT
Stock grant
8,044——8,044Feb 28, 2023Mar 1, 2023 ↗View →
CE
CELANESE CORP
PURCHASE
SVP - Acetyls
1,200$117.15$140.6K10,589Feb 28, 2023Mar 1, 2023 ↗View →
CE
CELANESE CORP
SALE
SVP - Acetyls
124$121.56$15.1K9,389Feb 15, 2023Feb 17, 2023 ↗View →
AVTR
AVANTOR, INC.
SALE
EVP, Biomaterials & AT
918$37.50$34.4K18,680Jan 13, 2022Jan 18, 2022 ↗View →
AVTR
AVANTOR, INC.
PURCHASEGRANT
Stock grant
26,347——26,347Feb 25, 2021Mar 1, 2021 ↗View →
AVTR
AVANTOR, INC.
PURCHASEGRANT
Stock grant
8,140——19,598Feb 25, 2021Mar 1, 2021 ↗View →
AVTR
AVANTOR, INC.
SALE
EVP, Biomaterials & AT
918$29.20$26.8K11,458Jan 13, 2021Jan 15, 2021 ↗View →
AVTR
AVANTOR, INC.
PURCHASEGRANT
Stock grant
120,107——120,107Jan 13, 2020Jan 15, 2020 ↗View →
AVTR
AVANTOR, INC.
PURCHASEGRANT
Stock grant
12,376——12,376Jan 13, 2020Jan 15, 2020 ↗View →
Other insiders · AVTR
Loading peer insiders…
About this filer
CIK 0001800013
ROLE
EVP, Biomaterials & AT
PRIMARY
AVTR
COMPANIES
2
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001800013DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback